We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$514M
AUM Growth
-$3.94M
Cap. Flow
-$4.39M
Cap. Flow %
-0.85%
Top 10 Hldgs %
15.77%
Holding
383
New
3
Increased
Reduced
1
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 15.23%
3 Financials 14.38%
4 Industrials 11.7%
5 Consumer Discretionary 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$23.9M 4.65%
762,000
JPM icon
2
JPMorgan Chase
JPM
$935B
$9.15M 1.78%
135,000
MSFT icon
3
Microsoft
MSFT
$3.45T
$8.17M 1.59%
185,000
JNJ icon
4
Johnson & Johnson
JNJ
$618B
$6.82M 1.33%
70,000
XOM icon
5
ExxonMobil
XOM
$644B
$5.82M 1.13%
70,000
DIS icon
6
Walt Disney
DIS
$167B
$5.71M 1.11%
50,000
WFC icon
7
Wells Fargo
WFC
$261B
$5.62M 1.09%
100,000
PG icon
8
Procter & Gamble
PG
$336B
$5.48M 1.07%
70,000
MRK icon
9
Merck
MRK
$322B
$5.31M 1.03%
97,728
PFE icon
10
Pfizer
PFE
$143B
$5.06M 0.99%
159,108
THC icon
11
Tenet Healthcare
THC
$20.5B
$4.92M 0.96%
85,000
PM icon
12
Philip Morris
PM
$297B
$4.81M 0.94%
60,000
GILD icon
13
Gilead Sciences
GILD
$162B
$4.68M 0.91%
40,000
AMZN icon
14
Amazon
AMZN
$2.92T
$4.34M 0.84%
200,000
CSCO icon
15
Cisco
CSCO
$457B
$4.12M 0.8%
150,000
ORCL icon
16
Oracle
ORCL
$374B
$4.03M 0.78%
100,000
IONS icon
17
Ionis Pharmaceuticals
IONS
$8.6B
$4.03M 0.78%
70,000
LOW icon
18
Lowe's Companies
LOW
$117B
$4.02M 0.78%
60,000
MO icon
19
Altria Group
MO
$114B
$3.91M 0.76%
80,000
AXP icon
20
American Express
AXP
$227B
$3.89M 0.76%
50,000
ALK icon
21
Alaska Air
ALK
$5.29B
$3.87M 0.75%
60,000
ALKS icon
22
Alkermes
ALKS
$8.22B
$3.86M 0.75%
60,000
LLY icon
23
Eli Lilly
LLY
$1.02T
$3.76M 0.73%
45,000
USB icon
24
US Bancorp
USB
$98.2B
$3.47M 0.68%
80,000
CVX icon
25
Chevron
CVX
$392B
$3.38M 0.66%
35,000

Similar funds

NJ State Employees Deferred Compensation Plan's Q2 2015 Portfolio in Review

As of Q2 2015, NJ State Employees Deferred Compensation Plan held 383 positions worth $514M, down 0.76% from $518M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 2.3%. NJ State Employees Deferred Compensation Plan opened 3 new positions and exited 6, leaving the 383-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q2 2015 buy was Xenon Pharmaceuticals: 20,000 shares worth $231K.
  • NJ State Employees Deferred Compensation Plan's biggest Q2 2015 reduction was Alphabet (Google) Class C, cutting an estimated $3.43K.
  • NJ State Employees Deferred Compensation Plan fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.05M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $514M portfolio in Q2 2015.
  • NJ State Employees Deferred Compensation Plan opened 3 new positions and closed 6 in Q2 2015.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 0.76% quarter-over-quarter to $514M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2015, filed 6 Aug 2015.